ID | Name | Number of studies | |
---|---|---|---|
CL_0000625 | CD8-positive, alpha-beta T cell | 55 | |
CL_0000900 | naive thymus-derived CD8-positive, alpha-beta T cell | 21 |
Gene | Number of supported studies | Average coverage | Other major groups (express this gene) | Other cell types (express this gene) | |
---|---|---|---|---|---|
CD8B | 14 | 74% ± 17% | 0 | 12 | |
GZMM | 13 | 48% ± 14% | 0 | 27 | |
ITK | 11 | 30% ± 8% | 0 | 22 | |
THEMIS | 10 | 26% ± 5% | 0 | 17 | |
ZAP70 | 11 | 37% ± 8% | 0 | 27 | |
FLT3LG | 10 | 43% ± 14% | 0 | 17 | |
CD8A | 14 | 65% ± 16% | 1 | 15 | |
TCF7 | 15 | 53% ± 19% | 1 | 27 | |
CD3G | 14 | 60% ± 14% | 1 | 29 | |
FCMR | 13 | 36% ± 12% | 1 | 27 | |
CD27 | 13 | 47% ± 16% | 1 | 30 | |
CD3D | 15 | 76% ± 21% | 2 | 34 | |
CD96 | 14 | 36% ± 10% | 2 | 33 | |
LCK | 14 | 60% ± 16% | 2 | 34 | |
BCL11B | 13 | 32% ± 17% | 2 | 27 | |
CD2 | 13 | 53% ± 14% | 2 | 35 | |
PASK | 10 | 28% ± 14% | 2 | 9 | |
TRABD2A | 10 | 29% ± 12% | 2 | 9 | |
CCR7 | 14 | 47% ± 15% | 3 | 17 | |
LEF1 | 13 | 49% ± 15% | 3 | 16 | |
CD3E | 14 | 88% ± 12% | 3 | 37 | |
CD7 | 14 | 66% ± 18% | 3 | 37 | |
LAT | 13 | 44% ± 14% | 3 | 29 | |
GIMAP7 | 14 | 59% ± 13% | 3 | 41 | |
SELL | 14 | 59% ± 19% | 3 | 43 | |
CAMK4 | 13 | 37% ± 11% | 3 | 34 | |
DGKA | 12 | 30% ± 12% | 4 | 20 | |
LTB | 15 | 68% ± 22% | 4 | 50 | |
CTSW | 13 | 54% ± 19% | 4 | 31 | |
FYB1 | 15 | 68% ± 17% | 4 | 51 |
GO_1905581 | Biological process | positive regulation of low-density lipoprotein particle clearance |
GO_0070092 | Biological process | regulation of glucagon secretion |
GO_0038110 | Biological process | interleukin-2-mediated signaling pathway |
GO_0006997 | Biological process | nucleus organization |
GO_0045324 | Biological process | late endosome to vacuole transport |
GO_0070233 | Biological process | negative regulation of T cell apoptotic process |
GO_0045719 | Biological process | negative regulation of glycogen biosynthetic process |
GO_0034383 | Biological process | low-density lipoprotein particle clearance |
GO_0090205 | Biological process | positive regulation of cholesterol metabolic process |
GO_0043576 | Biological process | regulation of respiratory gaseous exchange |
GO_0010458 | Biological process | exit from mitosis |
GO_0070670 | Biological process | response to interleukin-4 |
GO_0043392 | Biological process | negative regulation of DNA binding |
GO_0006900 | Biological process | vesicle budding from membrane |
GO_1904903 | Biological process | ESCRT III complex disassembly |
GO_0070669 | Biological process | response to interleukin-2 |
Cell type name | naive thymus-derived CD8-positive, alpha-beta T cell |
Synonyms | naive thymus-dervied CD8-positive alpha-beta T lymphocyte naive thymus-dervied CD8-positive alpha-beta T-cell naive thymus-dervied CD8-positive alpha-beta T-lymphocyte |
Description | A CD8-positive, alpha-beta T cell that has not experienced activation via antigen contact and has the phenotype CD45RA-positive, CCR7-positive and CD127-positive. This cell type is also described as being CD25-negative, CD62L-high and CD44-low. |
Parent | CL_0000625 |